For the Inventor, By the Inventor

Enter assignee name

Kinki University

USPTO Granted Patents = 50

EPO Patents = 27

Trademarks = 2

Forward Citations = 45

Loading Chart...

Loading Chart...

142 inventors (with patents filed for the assignee):

Atsufumi Kawabata (6 out of 8 patents)

Tamio Ida (4 out of 4 patents)

Kazuhiko Nakagawa (3 out of 4 patents)

4. Shunji Ishiwata (3 out of 4 patents)

5. Atsushi Taga (3 out of 4 patents)

6. Hiroyuki Nishikawa (3 out of 8 patents)

7. Osamu Muraoka (3 out of 3 patents)

8. Shigeki Hontsu (3 out of 3 patents)

9. Hiroaki Nishikawa (3 out of 3 patents)

10. Masanobu Kusunoki (3 out of 3 patents)

11. Takeharu Etoh (3 out of 14 patents)

12. Hiroto Tanaka (2 out of 4 patents)

13. Toru Ogawa (2 out of 3 patents)

14. Masayuki Igarashi (2 out of 15 patents)

15. Isao Ooi (2 out of 7 patents)

Core Competencies:

Cancer Cell Growth Inhibition

Ocular Surface Drug Retention

Intervertebral Disc Degeneration

Biomarker Selection

Peripheral Sensory Neuropathy

T-Type Calcium Channel Inhibition

Nanoparticle Production

Anticancer Agent Degradation

Hard Tissue Regeneration

Friction Stir Processing

Biocompatible Transparent Sheets

Chemical Sensor Devices

50 patents: Sort by Forward Citations

1. 12338198 - Cancer cell growth inhibiting composition and processed food (2025-06-24),

2. 12102713 - Ocular surface drug retention agent, eye drop containing the same, and method for retention of ocular surface drug using the same and method for treating ocular disease (2024-10-01),

3. 11951231 - Therapeutic agent for intervertebral disc degeneration and material for culturing inter vertebral disc cells (2024-04-09),

4. 11879150 - Treatment selection method and biomarker indicating selection (2024-01-23),

5. 11873344 - Protein biomarker and uses thereof (2024-01-16),

6. 11793845 - Composition for ameliorating peripheral sensory neuropathy (2023-10-24),

7. 11479537 - T-type calcium channel inhibitor (2022-10-25),

8. 11446608 - Method for reducing HTO concentration in aqueous solution (2022-09-20),

9. 11432552 - Deodorizing/antibacterial agent (2022-09-06),

10. 11420944 - Voltage-dependent t-type calcium channel blocker (2022-08-23),

11. 11371995 - Method for selecting individuals to be administered immune checkpoint inhibitor (2022-06-28),

12. 11370761 - Voltage-dependent T-type calcium channel inhibitor (2022-06-28),

13. 10758583 - Processed food and pharmaceutical composition having watermelon sprout-derived substances as main ingredients (2020-09-01),

14. 10709767 - Agent for prophylactic and/or therapeutic treatment of peripheral neuropathic pain caused by anticancer agent (2020-07-14),

15. 10696878 - Fluorene derivative, method for producing the same, resin composition, and article (2020-06-30),

Kinki University, located in Japan, is a prestigious higher education institution offering a wide range of academic programs. With a history of over 70 years, Kinki University is dedicated to providing quality education and fostering academic excellence. The university's website provides comprehensive information about its faculties, research centers, admission process, and various academic resources available to students. Visit Kinki University's website to explore the opportunities and experience the academic atmosphere offered by this esteemed institution.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

50 Patents

#160 in Osaka

#1,674 in Japan

#13,590 in the World

Kinki University

Forward Citations = 45

142 inventors:

Atsufumi Kawabata (6 out of 8 patents)

Tamio Ida (4 out of 4 patents)

Kazuhiko Nakagawa (3 out of 4 patents)

4. Shunji Ishiwata (3 out of 4 patents)

5. Atsushi Taga (3 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…